FzioMed Announces Addition of Industry Veteran to its Board of Directors

Company sets refreshed global strategy and new US initiatives for Oxiplex® portfolio of adhesion barrier products in women’s health, spine, orthopedics and general surgery. SAN LUIS OBISPO, Calif., May 17, 2023 /PRNewswire/ — FzioMed, Inc. (“FzioMed” or the “Company”), a global leading surgical biomaterials company focused on spine, orthopedic, peritoneal and gynecological surgery, today announced … Read more